The High Expression of Adhering and Circulating Integrin Serves as a Diagnostic Marker in Venous Thromboembolism

Fan Yang1, Yanli Song2, Haoming Song3

  • 1Department of Clinical Laboratory, Tongji Hospital, Tongji University School of Medicine, Shanghai, 200065, China.

Insights

Circulating integrins beta1, beta2, and beta3 show promise as biomarkers for diagnosing venous thromboembolism (VTE). Elevated levels in serum and on cells indicate high diagnostic accuracy for VTE detection.

Area of Science:

  • Biochemistry
  • Hematology
  • Medical Diagnostics

Background:

  • Venous thromboembolism (VTE) poses a significant health risk.
  • Accurate and early diagnosis of VTE is crucial for effective treatment.
  • Integrins play roles in cellular adhesion and immune responses, potentially relevant to thrombosis.

Purpose of the Study:

  • To evaluate the diagnostic utility of circulating integrins beta1, beta2, and beta3 in patients with VTE.
  • To determine the correlation between circulating and adhering integrin levels in VTE.
  • To assess the sensitivity and specificity of these integrins as VTE biomarkers.

Main Methods:

  • Flow cytometry was used to measure adhering integrins beta1, beta2, and beta3 on leukocytes and platelets.
  • Enzyme-linked immunosorbent assay (ELISA) quantified circulating integrins beta1, beta2, and beta3 in serum.
  • A cohort of 474 VTE patients and 306 controls was analyzed.

Main Results:

  • Significantly higher levels of integrins beta1, beta2, and beta3 were observed in the serum and on the surface of leukocytes and platelets in VTE patients.
  • Positive correlations were found between circulating and adhering integrin levels.
  • Circulating integrins demonstrated excellent clinical diagnostic performance for VTE.

Conclusions:

  • Integrin subunit beta (specifically beta1, beta2, and beta3) shows potential as a diagnostic marker for VTE.
  • These circulating integrins offer high sensitivity and specificity for venous thromboembolism diagnosis.
  • Further research may establish integrins as reliable biomarkers for VTE.
Abstract

Related Concept Videos

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
28
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
31
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
2.8K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
18
Integrins01:10

Integrins

Animal and protozoan cells do not have cell walls to help maintain shape and provide structural stability. Instead, these eukaryotic cells secrete a sticky mass of carbohydrates and proteins into the spaces between adjacent cells. This network of proteins and molecules is called an extracellular matrix or ECM.
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
4.1K
Varicose Veins II: Diagnostic Studies and Interprofessional Care01:26

Varicose Veins II: Diagnostic Studies and Interprofessional Care

Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
24